PhD Th esis - PhD ID: 1071 1527 - Information and Library ...shodhganga.inflibnet.ac.in/bitstream/10603/72709/15/15...PhD Th esis - PhD ID: 1071 1527 JJTU, DEPARTMENT OF PHARMACEU

PhD ID: 10711527

PhD Thesis- PhD ID: 10711527

7 JJTU, DEPARTMENT OF PHARMACEU

UTICAL SCIENCES Page 368


PhD ID: 10711527 JJTU, DEPARTMENT OF PHARMACEUTICAL SCIENCES Page 369369

REFERANCES

1. Abhinav Goyal & Salim Yusuf; September 2006; Indian J Med Res 124,pp 235-244

The burden of cardiovascular disease in the Indian subcontinent.

2. Ahlneck, C.; Zografi, G. The molecular basis of moisture effects on the physical and

chemical stability of drugs in the solid state. Int. J. Pharm.1990, 62, 87–95

3. Ahmed Salah U; et al. 2009 WO2009097156 (A1) & US2009196935 (A1)

4. Ahuja N., Katare O, Singh B,(2007); Studies on dissolution enhancement and

mathematical modelling of drug release of a poorly water-soluble drug using water-

soluble carriers, European Journal of Pharmaceutics and Biopharmaceutics (65) 26–

38.

5. Ali rajabi-Siahboomi,(2000); An Over view of Current Oral Modified Release

Technologies; Drug Delivery ORAL; 181-183

6. Amidon, G.L., Lennernas, H., Shah, V.P., Crison, J.R., (1995); A theoretical basis for

a bio-pharmaceutics drug classification: the correlation of in vitro drug product

dissolution and in vivo bioavailability. Pharm. Res. 12, 413–420.

7. Amidon, G.L., Lennernas, H., Shah, V.P., Crison, J.R., (1995); A theoretical basis for

a bio-pharmaceutics drug classification: the correlation of in vitro drug product

dissolution and in vivo bioavailability. Pharm. Res. 12, 413–420.

8. Amighi, K., Moes, A.J., (1995); Evaluation of thermal and film forming properties of

acrylic aqueous polymer dispersion blends: application to the formulation of

sustained-release film coated theophylline pellets. Drug Dev. Ind. Pharm. 21, 2355–

2569.

9. Amighi, K., Moes, A.J., (1995); Evaluation of thermal and film forming properties of

acrylic aqueous polymer dispersion blends: application to the formulation of

sustained-release film coated theophylline pellets. Drug Dev. Ind. Pharm. 21, 2355–

2569

10. Anaoui, A., Vergnaud, J.M, (2000): Effect of the nature of the polymer and of the

process of drug release (diffusion or erosion) for oral dosage forms. Computational

and Theoretical Polymer Science, volume 10, 383-390.

11. Atul M. Mehta (1986); Factors in development of controlled release pellets,

Pharmaceutical Technology Encyclopaedia



12. Atul M. Mehta, Michael J.Valazza, Stephen E.Abele (Jun 1986); Evaluation of Fluid

Bed processing for Enteric Coating system, Pharmaceutical Technology

Encyclopaedia.

13. Avshalom B.M, llan z, Dipyridamole and acetylsalicylic acid formulations and

process for preparing same; WO 2010036975 A3; Teva Pharmaceuticals Ltd; Sep 25,

2009

14. B. C. Lippold, B. H. Lippold, B. Sutter, and W. Gunder, Drug Dev. Ind. Pharm.

16(11): 1725 (1990

15. Badawy, S.I.F.; Williams, R.C.; Gilbert, D.L. Effect of different acids on solid state

stability of an ester prodrug of a glycoprotein IIb/IIIa receptor antagonist. Pharm.

Dev. Technol. 1999, 4 (3)325–331.

16. Baizhong Xue; et al. 2009 CN101428030 (A)

17. Bauer, K. H., Lehmann, K., Osterwald, H. P., Rothgang, G. (1998) Equipment for

sugar coating and film coating processes Coated pharmaceutical dosage forms.

Medpharm Scientiphic Publishers, Stuttgart

18. Ben-menachem avshalom; et al. 2010 WO2010036975 (A2) & US 2010/0080846

A1

19. Bodmeir and Paeratakul et al . Bodmeier and O. Paeratakul, Pharm. Res. 6:725 (1989)

20. Brahma N. Singh (2007); Modified-Release Solid Formulations for Colonic Delivery

Recent Patents on Drug Delivery & Formulation,(1), 53-63.

21. Bridget B. Kelly; Institute of Medicine; Fuster, Valentin (2010). Promoting

Cardiovascular Health in the Developing World: A Critical Challenge to Achieve

Global Health. Washington, D.C: National Academies Press. ISBN 0-309-14774-3.

22. Brittain, G. H., Bogdanowich, J. S., Bugay, J. V., Lewen, G., Newman, W. A. (1991)

Physical characterization of pharmaceutical solids. Pharmaceutical Research 8:963-

973

23. Brown, C., Chokshi, H., Nickerson, B., Reed, R., Rohrs, B., Shah, P. (2004)

Acceptable analytical practices for dissolution testing of poorly soluble compounds.

Pharmaceutical Technology

24. C. Lipinski, (2002); Poor aqueous solubility – an industry wide problem in drug

delivery, Am. Pharm. Rev. (5) 82–85.

25. C. M. Lancaster and M. A. Wheatley, Drug Delivery to the Colon, Poly. Prepr.

30(1):480 (1989)



26. Costa, F. O., Pais, A. A. C. C., Sousa, J. J. S. (2004) Analysis of formulation effects

in the dissolution of ibuprofen pellets. International Journal of Pharmaceutics 270:9-

19

27. Countries, Committee on Preventing the Global Epidemic of Cardiovascular Disease:

Meeting the Challenges in Developing; Fuster, Board on Global Health ; Valentin;

Academies, Bridget B. Kelly, editors ; Institute of Medicine of the National

(2010). Promoting cardiovascular health in the developing world : a critical

challenge to achieve global health. Washington, D.C.: National Academies Press.

pp. Chapter 2. ISBN 978-0-309-14774-3.

28. Dantas AP, Jimenez-Altayo F, Vila E (August 2012). "Vascular aging: facts and

factors". Frontiers in Vascular Physiology 3 (325): 1–

2. doi:10.3389/fphys.2012.00325.PMID 22934073.

29. Dashevsky, A., Wagner, K., Kolter, K., Bodmeier, R. (2005) Physicochemical and

release properties of pellets coated with Kolicoat SR 30D, a new aqueous polyvinyl

acetate dispersion for extended release. International Journal of Pharmaceutics 290:

15-23

30. Dashevsky, A., Wagner, K., Kolter, K., Bodmeier, R. (2005) Physicochemical and

release properties of pellets coated with Kolicoat SR 30D, a new aqueous polyvinyl

acetate dispersion for extended release. International Journal of Pharmaceutics 290:

15-23

31. David M. Jones, (Jan 1988): Air suspension coating, Pharmaceutical Technology

Encyclopedia

32. David M. Jones, Air suspension coating, Pharmaceutical Technology Encyclopedia

Jan 1988.

33. David M. Jones, Atul M. Mehta, (Jun 1985): coated pellets under microscope,

Pharmaceutical Technology Encyclopaedia

34. Davies, S.S., Wilson, C. G., and Washington, N., (1987): Gastrointestinal transit of a

controlled-release pellet formulation of tiaprofenic acid and the effect of food. Int. J.

Pharm. 35, 253-258

35. Deasy, P. B.; Murtagh, P. W.From Journal of Microencapsulation, 1996, 13(4), 385-

394

36. E. M.G. van Bommel, J. G. Fokkens, and D. J. A. Crommalin, Acta Pharm. Technol.

35(4):232 (1989)]

37. E. P. (2005) Methods of analysis, Chapter 2.2.42. Density of solids



38. Eisert , et al. 1995; US6015577

39. Eisert W, Gruber P; Pharmaceutical compositions containing dipyridamole or

mopidamol and acetylsalicylic acid or the physiologically acceptable salts thereof,

processes for preparing them and their use in treating clot formation ; US Patent

6,015,577 ; Thomae GmbH; Dr. Karl; April 12, 1995

40. Ensslin, S., Moll, K.P., Haefele-Racin, T., Maeder, K., (2009); Safety and robustness

of coated pellets: self-healing film properties and storage stability. Pharm. Res. 26,

1534–1543.

41. F. Norring Christensen and P. Bertelsen; (1997) Qualitative description of the Wurster

based fluid bed coating process- Drug Development and Industrial pharmacy, 23(5),

451-463.

42. F. W. Goodhart, M. R. Harris, K. S. Murthy, and R. U. Nesbitt, Pharm. Technol.

8(4):64 (1984

43. F.O. Costa, J.J.S. Sousa, A.A.C.C. Pais, S.J. Formosinho (2003); Comparison of

dissolution profiles of Ibuprofen pellets Journal of Controlled Release (89) 199–212

44. Felton, L. A. (2007) Film Coating of Oral Solid Dosage Form. In: Swarbrick, J. (ed.)

Encyclopedia of Pharmaceutical Technology. Third edn. Informa Helathcare, pp 1729

- 1747

45. Finegold, JA; Asaria, P; Francis, DP (Dec 4, 2012). "Mortality from ischaemic heart

disease by country, region, and age: Statistics from World Health Organisation and

United Nations.". International journal of cardiology 168 (2): 934–

45. doi:10.1016/j.ijcard.2012.10.046.PMID 23218570.

46. Fonner, D. E., Anderson, R. N., Banker, S. G. (1981) Granulation and tablet

characteristics. In: Lachman, L. (ed.) Pharmaceutical dosage forms: Tablets. Marcel

and Dekker, New York, pp 185-266

47. Frohoff-Huelsmann, M.A., Lippold, B.C., McGinity, J.W., (1999); Aqueous ethyl

cellulose dispersion containing plasticizers of different water solubility and

hydroxypropyl methyl cellulose as coating material for diffusion pellets I: drug

release rates from coated pellets. Int. J. Pharm. 177, 69–82

48. Frohoff-Huelsmann, M.A., Lippold, B.C., McGinity, J.W., (1999); Aqueous ethyl

cellulose dispersion containing plasticizers of different water solubility and

hydroxypropyl methyl cellulose as coating material for diffusion pellets I: drug

release rates from coated pellets. Int. J. Pharm. 177, 69–82



49. G. I. Amer, J. N. Foster, and C.P. Iovine, European Patent Application 0292314 A2

(1988)

50. G. Kallstrand, and B. Ekman, J. Pharm. Sci. 72(7):772 (1983

51. G. S. Banker, J. Pharm. Sci. 58:81 (1966)

52. G. S. Rekhi, R. W. Mendes, S. C. Porter, and S. S. Jambhekar, Pharm. Technol.

13(3):112 (1989)].

53. G.L. Brown, J. Polym. Sci. 22:423 (1956

54. Ghebre-Sellassie, I. (1989a) Pellets: A General Overview. In: Ghebre-Sellassie, I.

(ed.) Pharmaceutical Pelletization Technology. Marcel Dekker, New York, pp 1-13

55. Ghebre-Sellassie, I., (1994); Multiparticulate Oral Drug Delivery. Dekker, New York,

USA

56. Ghebre-Sellassie, I., Knoch, A. (2002) Pelletization techniques Encyclopedia of

Pharmaceutical Technology. 3rd edn. Informa Healthcare

57. Gilbert James C; et al. [2008] US2008188497 (A1)

58. Go AS et al 2013; Executive summary: heart disease and stroke statistics--2013

update: a report from the American Heart Association; 2013 Jan 1;127(1):143-52. doi:

10.1161/CIR.0b013e318282ab8f

59. Goran Frenning, A sa Tuno, Goran Alderborn,(2003); Modelling of drug release from

coated granular pellets; Journal of Controlled Release (92) 113–123

60. Gruber; et al. 1980; US 4,367,217

61. Gu, L., Liew, C. V., Heng, P. W. S. (2004) Wet spheronization by rotary processing –

A multistage single-pot process for producing spherodis. Drug Development and

Industrial Pharmacy 30: 111-123

62. Guangyan Wu; et al. 2008 CN201299813 (Y)

63. Gursoy, D. Karakus, I. Okar; 1999, Vol. 16, No. 4 , Pages 439-452; Journal of

Microencapsulation

64. H. Burrell, in Polymer Handbook, 2nd ed., (J. Brandrup and E. H. Immergut, eds.),

Wiley-Interscience, New York, 1975, pp. 337-360

65. H. Kranz, V. Le Brun, T. Wagner, (2005); Development of a multi particulate

extended release formulation for ZK 811 752, a weakly basic drug International

Journal of Pharmaceutics (299) 84–91.

66. H.Nakagami, T.Keshikawa, M. Matsumura, and H. Tsukamoto, Chem. Pharm. Bul.

39:1837 (1991)]



67. Harlan S Hall (2004); scaling of Fluid bed Coating, coating Place Inc.; Business

briefing pharma tech

68. Irwin, W.J.; Iqbal, M. Solid-state stability: the effect of grinding solvated excipients.

Int. J. Pharm. 1991, 75, 211–218

69. J. Hilderbrand and R. Scott, The Solubility of Non-electrolytes, 3rd ed., Reinhold,

New York, 1949]

70. J. Hu, K.P. Johnston, R.O. Williams III, (2004) ; Rapid dissolving high potency

danazol powders produced by spray freezing into liquid process, Int. J. Pharm. (271)

145–154.

71. J. M. Waldie, Surface Coating, Vol. 1, Raw Materials and Their Usage, Chapman &

Hall, New York, 1981

72. J. Siepmann, F. Lecomte, R. Bodmeier; (1999); Diffusion-controlled drug delivery

systems: calculation of the required composition to achieve desired release profiles

Journal of Controlled Release (60) 379–389

73. J. T. Fell, Gastrointestinal Transit of Microcapsules, Chapter 8 in Microcapsules and

Nanoparticles in Medicine and Pharmacy, (M. Donbrow, ed.) CRC Press, Boca

Raton, Fla., 1992

74. J. W. Parker, G. E. Peck, and G. S. Banker, J. Pharm. Sci.63(1):119 (1974)]

75. J.W. Vanderhoff, H.L Tarkowski, M.C. Jenkins, and E. B. Bradford, J. Marcomol.

Chem. 1:361 (1966)]

76. Jan Ploen, Jens Andersch, Michael Heschel and Claudia S. Leopold; Citric acid as a

pH-modifying additive in an extended release pellet formulation containing a weakly

basic drug; Drug Development and Industrial Pharmacy, 2009; 35(10): 1210–1218

77. John collett, Chris moreton, (2002): Modified release per oral dosage forms. In:

Pharmaceutics- The Science of Dosage form Design, by Michael E. Aulton.

78. Jones, D. M. (2005a) Dry powder layering of nuclei. Pelletization techniques, TTC

Workshop. Binzen, Germay

79. Jong Soo Woo et al Complex formulation comprising aspirin coated with barrier

containing hydrophobic additive, and hmg-coa reductase inhibitor; WO 2011096665

A2; Hanami holdings co ltd; Jan 26,2011

80. Jun Young Choi et al Pharmaceutical composite formulation comprising hmg-coa

reductase inhibitor and aspirin; WO 2012081905 A2; Hanami holdings co ltd; Dec 14,

2011



81. K. H. Bauser, K. Lehmann, H. P. Osterwald, and G. Rothgang, Uberzogene

Arzneiformen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1988, p.78

82. K. Lehmann and D. Dreher, Coating small particles with acrylic resins, Pharm.

Technol, 3:53 (1979)]

83. K. Lehmann, Chemistry and application properties of polymethacrylate coating

systems, Chapter 4, in Aqueous Polymeric Coating for Pharmaceutical dosage Forms,

(J. W. McGinity, ed.) Marcel Dekker, New York, 1989]

84. K. Lehmann, Programmed drug release from oral dosage forms, Pharma. Int. 3:34

(1971)

85. K. Srinath Reddy and Salim Yusuf; [1998]; 97;596-601 Emerging Epidemic of

Cardiovascular Disease in Developing Countries

86. K. Vasilevska, Z. Djuric, M. Jovanovic, M. Strupar, and A. Simov, Pharmazie 46:54

(1991).

87. K.O.R Lehmann, in Aqueous Polymeric Coating for pharmaceutical Dosage Forms

(J.W. McGinity, ed.), Marcel Dekker, New York, 1989, p. 153

88. Khosla, R., Feely, L. C., and Davis, S. S., (1989): Gastrointestinal transit of non

disintegrating tablets in fed subjects. Int. J. Pharm. 53, 107-117.

89. Kleinebudde, P., Knop, K. (2007) Direct pelletization of pharmaceutical pellets in

fluid bed processes. In: Seville, J. P. K. (ed.) Granulation. Elsevier, pp 780-811

90. Korakianiti, S. E., Rekkas, D. M., Dallas, P. P., Choulis, H. N. (2000) Optimization of

the Pelletization Process in a Fluid-Bed Rotor Granulator Using Experimental Design.

AAPS Pharmsci 1: 1-5 Korakianti, E. S. (2002) STP Pharma Sci 12: 191

91. L. Shargel, S. Wu-Pong, A. Yu, (2005) Applied Bio pharmaceutics &

Pharmacokinetics, 5th ed. McGraw-Hill, New York.

92. L.V. Allen, N.G. Popovich, H.C. Ansel, (2010); Ansel's Pharmaceutical Dosage

Forms and Drug Delivery Systems, 9th ed. Lippincott Williams & Wilkins,

Philadelphia.

93. Lachman, L., Lieberman, H.A., Kanig, J.L.(1990) The Theory and Practice of

Industrial Pharmacy.; Varghese Publishing House, Bombay, India, 3rd edition 430-

490.

94. Langer, R.S., Wise, D.L., (1984): Medical Applications of Controlled Release, vol. I.

CRC Press, Boca Raton, FL.

95. Langer, R.S., Wise, D.L., (1984): Medical Applications of Controlled Release, vol. II.

CRC Press, Boca Raton, FL



96. Lecomte, F., Siepmann, J., Walther, M., MacRae, J. R. (2004) Polymer blends used

for the coating of multiparticulates: Comparison of aqueous and organic coating

techniques. Pharmaceutical Research 21

97. Lecomte, F., Siepmann, J., Walther, M., MacRae, R.J., Bodmeier, R., (2003); Blends

of enteric and GIT-insoluble polymers used for film coating: physicochemical

characterization and drug release patterns. J. Control. Release 89, 457–471.

98. Lehman, K. (1997) Chemistry and application properties of polymetacrylate coating

systems. In: McGinity, J. W. (ed.) Aqueous Polymeric Cotings for Pharmaceutical

Dosage Forms. Marcel Dekker, pp 101-176

99. Leibovici; Minutza; et al. 2007 US 2007/0184110 A1

100. M. D. Coffin, R. Bodmeier, K. Chang, and J. W. McGinity, The prepration,

characterization and evaluation of poly(dl-lactide) aqueous lactides, J. Pharm. Sci.

76:261 (1987).].

101. M. Litinski, F.A Scheer, S.A Shea, (2009); Influence of the circadian system on

disease severity, Sleep Med. Clin.4 143-163.

102. M. Marvola, M. Rajaniemi, E. Marttila, K. Vahervuo and A. Southmann, J. Pharm.

Sci. 72:1034 (1983).

103. M. Metha, Evaluation and Characterization of pellets, Chapter 11 in Pharmaceutical

pelletization Technology, (I. Ghebre-Sellassie, ed.) Marcel Dekker, New York,

1989.].

104. M. R. Harris and I. Ghebre-Sellassie, in Aqueous Polymeric Coating for

Pharmaceutical Dosage Forms (J. McGinity, ed.), Marcel Dekker, New York, 1989, p.

63

105. Maton, Anthea; Jean Hopkins, Charles William McLaughlin, Susan Johnson,

Maryanna Quon Warner, David LaHart, Jill D. Wright (1993). Human Biology and

Health. Englewood Cliffs, New Jersey: Prentice Hall. ISBN 0-13-981176-1.

106. McGill HC, McMahan CA, Gidding SS (March 2008). "Preventing heart disease in

the 21st century: implications of the Pathobiological Determinants of Atherosclerosis

in Youth (PDAY) study". Circulation 117 (9): 1216–

27.doi:10.1161/CIRCULATIONAHA.107.717033.PMID 18316498.

107. McGinity, J., Felton, L.A., (2008); Aqueous Polymeric Coatings for Pharmaceutical

Dosage Forms, third ed. In forma Healthcare, New York.

108. Mendis, S.; Puska, P.; Norrving, B.(editors) (2011), Global Atlas on cardiovascular

disease prevention and control,ISBN 978-92-4-156437-3



109. Mina Heidarian a, Albert Mihranyan a, Maria Strømmeb,, Ragnar Eka Influence of

water-cellulose binding energy on stability of acetylsalicylic acid; International

Journal of Pharmaceutics 323 (2006) 139–145

110. Ming Zhang; et al. 2008 CN201157559 (Y)

111. Minutza Leibovici; et al. 2008 HK1104791 (A1)

112. Nandita G. Das and Sudip K. Das., (2003): Controlled-Release of Oral Dosage Forms,

Formulation, Fill & Finish

113. Naonori Kohri, Natsumi Miyata, Masaki Takahashi, Harumi Endo, Ken Iseki,

Katsumi Miyazaki, Shigeru Takechi, Akikazu Nomura; International Journal of

Pharmaceutics; Volume 81, Issue 1, 15 March 1992, Pages 49–58

114. O. Okhamafe and P. York, J. Pharm. Sci. 77:438 (1988)

115. P. Giunchedi, U. Conte; L. Maggi; A. La Manna; 20 september 1992 , Volume 85,

Issues 1-3, International journal of Pharmaceutics ; Pages 141-147

116. P. Sakellariou, R. C. Rowe, and E. F. T. White, J. Appl. Polym. Sci. 34:2507 (1987).

117. Pallavi Bassi, Gurpreet Kaur, pH modulation: a mechanism to obtain pH-independent

drug release, Expert Opin. Drug Deliv. (2010) 7(7):845-857

118. Parikh, D. M. (2006) Batch size increase in fluid-bed granulation. In: Levin, M. (ed.)

Pharmaceutical

119. Pasahn Manohar; et al. 2010; EP2361615 (A1)

120. Patil Atul et al 2008 EP1894561 (A1)

121. Phuong Ha-Lien Tran, Thao Truong-Dinh Tran, Kyoung-Ho Lee, Dong-Jin Kim &

Beom-Jin Lee Dissolution-modulating mechanism of pH modifiers in solid dispersion

containing weakly acidic or basic drugs with poor water solubility, Expert Opin. Drug

Deliv. (2010) 7(5):647-661

122. Process Scale-up. CRC Press, New York, pp 267-324

123. R. C. Rowe, A. D. Koteras, and E. F. T. White, Int. J.Pharm. 22:57 (1984).]

124. R. C. Rowe, J. Pharm. Pharmacol. 38:214 (1986).

125. R.E. Dillon, L.A. Matheson, and E.B. Bradford, J.Colloid. Sci. 6:108 (1951)

126. Randall, C. S. (1995) Particle size distribution. In: Brittain, G. H. (ed.) Physical

characterization of pharmaceutical solids. Marcel Dekker, Inc., New York, pp 157-

186

127. Rashid, H. (2001) Centrifugal granulation process for preparing drug layered pellets

based on microcrystalline cellulose beads. Helsinki, Helsinki Rashid, H. A.,

Heinamaki,



128. Rawat P K, Pandey A K, Mote P B, Gulecha B S, Rajendra V B, Lahoti S R,

Formulation and development of aspirin / extended release dipyridamole Capsules;

Pelagia Research Library Der Pharmacia Sinica, 2012, 3 (5):569-575

129. Rongsheng Ma; et al. 2008 CN101259132

130. S. Ohdo, (2010); Chronopharmaceutics: pharmaceutics focused on biological rhythm

Biol. Pharm. Bull (33) 159-167.

131. S. T. Yang and I. Ghebre-Sellassie, Int. J. Pharm. 60:109 (1990)]

132. Shan Lin, Yoshiaki K, (2011); Current status and approaches to developing press

coated chrono delivery drug systems, Journal of controlled release.

133. Sherif Badawy, Rodney Vickery, Keyur Shah, and Munir Hussain, Effect of

Processing and Formulation Variables on the Stability of a Salt of a Weakly Basic

Drug Candidate pharmaceutical development and technology 2004,Vol. 9, No. 3, pp.

239–245

134. Siepe S, Herrmann W, Borchert HH, et al. Micro environmental pH and micro

viscosity inside pH-controlled matrix tablets: an EPR imaging study.J Control Release

2006;112:72-80

135. Stefanie Siepe ,Barbara Lueckel, Andrea Kramer, Angelika Ries, Robert Gurny;

(2006) ; strategies for the design of hydrophilic matrix tablets with controlled micro-

environmental pH International Journal of Pharmaceutics (316) 14–20.

136. Stefanie Siepe, Barbara Lueckel, Andrea Kramer, Angelika Ries and Robert Gurny

2008, Vol. 34, No. 1 , Drug development and Industrial pharmacy; Pages 46-52

137. Struebing, S., Metz, H., Maeder, K., (2007); Mechanistic analysis of drug release

from tablets with membrane controlled drug delivery. Eur. J. Pharm. Biopharm. (66),

113–119.

138. Swarbick James C Boylan James Absorption of Drugs ; Page 11 to 16, Encyclopedia

of Pharmaceutical Technology; A-D Vol 2

139. T.F. Protzman and G.L. Brown, J. Appl. Polym. Sci. 4:81 (1960)].

140. Thoma, K., Bechtold, K. (1999) Influence of aqueous coatings on the stability of

enteric coated pellets and tablets. European Journal of Pharmaceutics and

Biopharmaceutics 47: 39-50

141. Toyoshima, in Polyvinyl Alcohol (C. A. Finch, ed.), Wiley, New York, 1973, p.339

142. Ulrich Heigoldt, Florian Sommer, Rolf Daniels, Karl-Gerhard Wagner, (2010) ;

Predicting in vivo absorption behavior of oral modified release dosage forms

containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in



vitro dissolution test; European Journal of Pharmaceutics and Biopharmaceutics 76

105–111

143. Ulrich Heigoldt, Florian Sommer, Rolf Daniels, Karl-Gerhard

Wagner, (2010) ; Predicting in vivo absorption behavior of oral

modified release dosage forms containing pH-dependent poorly soluble

drugs using a novel pH-adjusted biphasic in vitro dissolution test;

European Journal of Pharmaceutics and Biopharmaceutics 76

105–111

144. US FDA, Guidance for Industry (August 2000), Waiver of in vivo

bioavailability and bioequivalence studies for immediate release solid oral

dosage forms based on a biopharmaceutics classification system.,

Center for Drug Evaluation and Research, Fishers Lane, Rockville, MD

pp. 1–13.

145. Varma MVS, Kaushal AM, Garg S. Influence of micro-environmental pH

on the gel layer behavior and release of a basic drug from various

hydrophilic matrices. J Control Release 2005;103:499-510

146. W. Rothe and G. Groppenbacher, Pharm. Ind 35:11 (1973)]

147. W.A. Henson, D.A.Taber, and B.E.Bradford, Ind. Eng.Chem. 45:735 (1953)

148. Waterman, K.C.; Adami, R.C.; Alsante, K.M.; Antipas, A.S.; Arenson,

D.R.; Carrier, R.; Hong, J.; Landis, .S.; Lombardo, F.; Shah, J.C.;

Shalaev, E.; Smith, S.W.; Wang, H. Hydrolysis in pharmaceutical

formulations. Pharm. Dev. Technol. 2002, 7 (2),

113–146

149. Weithmann, et al. 1985 US4,694,024

150. Wurster (1959), D.E.J. Am. Pharma. Assoc., 48:451.

151. Wurster D, “Method for Applying Coating to Tablets”, (1953), US Patent 2,648,609

152. Wurster D, D.E.J. Am. Pharma. Assoc., (1959) 48:451;

153. www.rxlist.com [Viewed 6th Dec 2013]

154. Y. Cuppok, S. Muschert, M. Marucci, J. Hjaertstam, F. Siepmann, A. Axelsson, J.

Siepmann; (2011);Drug release mechanisms from Kollicoat SR: Eudragit

NE coated pellets; International Journal of Pharmaceutics (409) 30–37.

155. Yang Wang Huailin Liu; et al. 2010; CN102210693



156. Zhang Jun; et al. 2011; CN102178671 (A)

Documents

PhD Th esis - PhD ID: 1071 1527 - Information and Library ...shodhganga.inflibnet.ac.in/bitstream/10603/72709/15/15...PhD Th esis - PhD ID: 1071 1527 JJTU, DEPARTMENT OF PHARMACEU